Floatz logo

VITAMIN D

Vitamin D Deficiency

Yale UniversitymixturePhase 4 / ApprovedActive
A
83/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
75/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Vitamin D Deficiency cohort.

Asset / SponsorPhaseRating
Metformin
Ain Shams University
Phase 4BBB
1,25-dihydroxyvitamin d
University Hospital Rijeka
Phase 4BB
Letrozole
Umm Al-Qura University
Phase 4BB
ERGOCALCIFEROLUM
Chulalongkorn University
Phase 4BB
Clomifene
Ain Shams University
Phase 4B

View all 16 →

Same molecule, other indications

VITAMIN D is also rated in:

osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →
Cerebral Vascular AccidentDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →